GSK (FRA:GS70) Other Operating Expense: €-1,712 Mil (TTM As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:GS70 GSK PLC FRA:GS70
82 GF Score
Price €43.40
GF Value €38.05
Valuation Modestly Overvalued
! 1 Warning Sign
View Full Analysis

What is GSK Other Operating Expense?

GSK FRA:GS70 -1.36% 82 Other Operating Expense is €-1,712 Mil as of Mar. 2026. GuruFocus rates FRA:GS70 with a GF Score™ of 82/100 and a GF Value™ of €38.05 (Modestly Overvalued). The stock has 1 warning sign investors should review.

GSK's Other Operating Expense for the three months ended in Mar. 2026 was €-404 Mil. Its Other Operating Expense for the trailing twelve months (TTM) ended in Mar. 2026 was €-1,712 Mil.

GSK's quarterly Other Operating Expense declined from Sep. 2025 (€-267 Mil) to Dec. 2025 (€-610 Mil) but then increased from Dec. 2025 (€-610 Mil) to Mar. 2026 (€-404 Mil).

GSK's annual Other Operating Expense increased from Dec. 2023 (€-1,381 Mil) to Dec. 2024 (€-761 Mil) but then declined from Dec. 2024 (€-761 Mil) to Dec. 2025 (€-1,487 Mil).

GSK Other Operating Expense Historical Data

* Premium members only.

The historical data trend for GSK's Other Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

GSK Other Operating Expense Chart

GSK Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Other Operating Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only -510.76 -941.70 -1,381.30 -760.62 -1,487.36

GSK Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Other Operating Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -201.97 -430.56 -267.11 -610.49 -403.67
FRA:GS70
82GF Score
GSK PLC FRA:GS70
Other Operating Expense is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

GSK Other Operating Expense Calculation

GuruFocus uses a standardized financial statement format for all companies. For non-financial companies, GuruFocus lists Selling, General, & Admin. Expense, , Research & Development, and Other Operating Expense under the "Total Operating Expense" section.

Other Operating Expense sometimes includes:
Restructuring, and merger
Acquisition related and other
Litigation settlement charge
Other (too numerous to list)

Some companies can and do choose to report each of these items separately. Yet, there are a variety of Other Operating Expense which are simply too numerous to list.

Other Operating Expense for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €-1,712 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Other Operating Expense of €-1,712 Mil mean?
GSK (FRA:GS70) has a Other Operating Expense of €-1,712 Mil as of Mar. 2026. Other operating expenses that a company records on its income statement. View historical data on GSK and its competitors.
Is GSK's Other Operating Expense too high?
GSK's current Other Operating Expense is €-1,712 Mil. Overall, GSK has a GF Score™ of 82/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does GSK's Other Operating Expense compare to LLY and JNJ?
GSK's Other Operating Expense of €-1,712 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Operating Expense for a Drug Manufacturers company?
A good Other Operating Expense depends on the Drug Manufacturers industry context. However, Other Operating Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Operating Expense mean?
A high Other Operating Expense can signal that a stock is expensive relative to its fundamentals. Other operating expenses that a company records on its income statement. View historical data on GSK and its competitors. GSK's current Other Operating Expense is €-1,712 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is GSK stock overvalued right now?
Based on GuruFocus' analysis, GSK (FRA:GS70) is currently considered Modestly Overvalued. The stock's GF Value™ is €38.05, compared to a current price of €43.40 — trading 14.1% above its estimated fair value. The current Other Operating Expense is €-1,712 Mil. GSK's overall GF Score™ is 82/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Operating Expense calculated?
Other Operating Expense is calculated from a company's financial statements. For GSK (FRA:GS70), the current Other Operating Expense is €-1,712 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is GSK (FRA:GS70) Overvalued in 2026?

Based on GuruFocus' analysis, GSK stock appears to be overvalued. The current stock price of €43.40 is trading 14.1% above its estimated GF Value™ of €38.05. GuruFocus considers GSK to be Modestly Overvalued.

Key valuation signals for FRA:GS70:

  • Other Operating Expense: €-1,712 Mil
  • GF Value™: €38.05 vs. price of €43.40 (14.1% above fair value)
  • GF Score™: 82/100 with 1 warning sign

No single metric tells the full story. See the FRA:GS70 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

GSK Business Description

Address 79 New Oxford Street, London, GBR, WC1A 1DG
In the pharmaceutical industry, GSK ranks as one of the largest firms by total sales. The company wields its might across several therapeutic classes, including respiratory, antiviral, and vaccines, and has been growing its presence in oncology and immunology, as well. GSK uses joint ventures to gain additional scale in certain markets like HIV.
82GF Score

Get the complete analysis for FRA:GS70

Other Operating Expense is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€43.40
Price
€38.05
GF Value